NPI | Name | Type | Address |
---|---|---|---|
DR. B.S. PHARM, PHARM.D. Theresa A Mays |
Individual |
4319 Medical Dr Suite 205 San Antonio, TX |
|
MR. RPH Chris A Sellers |
Individual |
5400 Kell Blvd Wichita Falls, TX |
|
MR. R.PH. James Richard Schwartz |
Individual |
3705 W 15th St Plano, TX |
|
MR. R.PH. Robert Duane Epps |
Individual |
910 E Houston St Ste 100 Tyler, TX |
|
RPH Joe D Crowley |
Individual |
1001 12th Ave Suite 200 Fort Worth, TX |
|
MRS. RPH Martha J Pineiro |
Individual |
3535 Worth St Ste 500 Dallas, TX |
|
MRS. R.PH. Eileen B Herbeck |
Individual |
1300 N 4th St Longview, TX |
|
RPH BCOP Megan Ouldhouse |
Individual |
7777 Forest Ln D-220 Dallas, TX |
|
RPH Karen Sue Amidon |
Individual |
4700 N Galloway Ave Mesquite, TX |
|
R.PH., BSPHARM Brian Travis |
Individual |
3720 South I-35e Denton, TX |
|
MR. R. PH. Ana M Larralde |
Individual |
1901 South Second Street Mcallen, TX |
|
PHARM D Yakeika Sims |
Individual |
3535 Worth Street Dallas, TX |
|
MRS. R.PH Shana Levine Gregory |
Individual |
690 14th St. Beaumont, TX |
|
DR. PHARMD Raquel Lashawn Rhone |
Individual |
3535 Worth St Ste 170 Dallas, TX |
|
MR. RPH Billy Bruce Boughton |
Individual |
3535 Worth St Dallas, TX |
|
MS. RPH Phoebe Jane Cook |
Individual |
3535 Worth St Ste 340 Dallas, TX |
|
DR. PHARM, D Allison Eisenmann |
Individual |
2790 Lake Vista Dr Lewisville, TX |
|
RPH Debra Michelle Hunter |
Individual |
301 North 'n' St Midland, TX |
|
RPH. Vincent Trung Nguyen |
Individual |
1350 First Colony Blvd Sugar Land, TX |
|
RPH BCOP Kim L Tanner |
Individual |
2790 Lake Vista Dr Lewisville, TX |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |